Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL558642 (GSK-650394) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
calcium/calmodulin dependent protein kinase kinase 2/Calcium/calmodulin-dependent protein kinase kinase 2 in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4295888] [GtoPdb: 1957] [UniProtKB: Q8C078] | ||||||||
ChEMBL | Inhibition of CAMKK2 in mouse N39 cells assessed as decrease in AMPKalpha phosphorylation at T172 preincubated for 80 mins followed by inomycin addition by ELISA | B | 5.9 | pIC50 | 1258.93 | nM | IC50 | Bioorg Med Chem Lett (2018) 28: 1958-1963 [PMID:29653895] |
calcium/calmodulin dependent protein kinase kinase 1/CaM-kinase kinase alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5256] [GtoPdb: 1956] [UniProtKB: Q8N5S9] | ||||||||
ChEMBL | Inhibition of human CAMKK1 using CAMKKtide as substrate assessed as residual activity by [gamma-33P]-ATP assay relative to control | B | 7.48 | pIC50 | 33 | nM | IC50 | J Med Chem (2021) 64: 10849-10877 [PMID:34264658] |
ChEMBL | Inhibition of CaMKK1 (unknown origin) incubated for 20 mins in presence of kinase tracer 236 by TR-FRET | B | 8.51 | pIC50 | 3.1 | nM | IC50 | J Med Chem (2023) 66: 15750-15760 [PMID:38009718] |
calcium/calmodulin dependent protein kinase kinase 2/CaM-kinase kinase beta in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5284] [GtoPdb: 1957] [UniProtKB: Q96RR4] | ||||||||
ChEMBL | Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay | B | 8.1 | pIC50 | 7.94 | nM | IC50 | Bioorg Med Chem Lett (2018) 28: 1958-1963 [PMID:29653895] |
ChEMBL | Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity by [gamma-33P]-ATP assay relative to control | B | 8.52 | pIC50 | 3 | nM | IC50 | J Med Chem (2021) 64: 10849-10877 [PMID:34264658] |
ChEMBL | Inhibition of NanoLuc-fused CAMKK2 (unknown origin) expressed in HEK293 cells after 24 hrs by NanoBRET assay | B | 8.52 | pIC50 | <3 | nM | IC50 | J Med Chem (2021) 64: 10849-10877 [PMID:34264658] |
ChEMBL | Inhibition of CaMKK2 (161 to 449 residues) (unknown origin) expressed in Escherichia coli BL21 (DE3) star cells incubated for 20 mins in presence of kinase tracer 236 by TR-FRET | B | 8.64 | pIC50 | 2.3 | nM | IC50 | J Med Chem (2023) 66: 15750-15760 [PMID:38009718] |
aurora kinase A/Serine/threonine-protein kinase Aurora-A in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4722] [GtoPdb: 1936] [UniProtKB: O14965] | ||||||||
ChEMBL | Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument | B | 6.53 | pKd | 298.01 | nM | Kd | K4DD drug target binding kinetics data |
serum/glucocorticoid regulated kinase 1/Serine/threonine-protein kinase Sgk1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2343] [GtoPdb: 1534] [UniProtKB: O00141] | ||||||||
ChEMBL | Inhibition of SGK1-mediated epithelial sodium channel activity in human M-1 cells assessed as short circuit current by whole cell electrophysiological transepithelial experiment | B | 6.24 | pIC50 | 580 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 4441-4445 [PMID:19497745] |
GtoPdb | - | - | 7.21 | pIC50 | 62 | nM | IC50 | Cancer Res (2008) 68: 7475-83 [PMID:18794135] |
ChEMBL | Inhibition of SGK1 by fluorescence polarization assay | B | 7.89 | pIC50 | 13 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 4441-4445 [PMID:19497745] |
ChEMBL | Inhibition of SGK1 expressed in Escherichia coli or baculovirus-infected insect cells by IMAP assay | B | 7.89 | pIC50 | 13 | nM | IC50 | J Med Chem (2011) 54: 5131-5143 [PMID:21699136] |
serum/glucocorticoid regulated kinase 2 in Human [GtoPdb: 1535] [UniProtKB: Q9HBY8] | ||||||||
GtoPdb | - | - | 6.99 | pIC50 | 103 | nM | IC50 | Cancer Res (2008) 68: 7475-83 [PMID:18794135] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]